Pliant Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.39-0.39-0.46-0.83
Price/Sales ratio
8.5814.771.160.32
Earnings per Share (EPS)
$-3.76$-3.84$-3.24$-1.79

Historical Multiples (2017 – 2023)

2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.82-11.614.09K-20.32-27.02-6.68-6.59-8.982.03K
Price/Sales ratio
N/AN/A13.2719.3163.9183.85673.03114.3916.29
Price/Book Value ratio
5.11-398.71-1.74K2.852.432.592.243.53-868.96
Price/Cash Flow ratio
-1.01-12.41-275.36-21.67-6.41-8.58-9.13-11.70-148.51
Price/Free Cash Flow ratio
-0.93-11.47-203.88-20.81-6.25-8.42-9.06-11.49-112.35
Price/Earnings Growth ratio
N/A0.12-40.810.000.48-0.011.361.01-20.40
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A100%100%57.68%61.99%100%51.51%78.84%
Operating Profit Margin
N/AN/A-2.15%-99.58%-263.94%-1313.37%-11654.74%-1313.37%-181.76%
Pretax Profit Margin
N/AN/A-1.10%-99.32%-260.35%-1273.31%-10211.13%-1273.31%-179.83%
Net Profit Margin
N/AN/A0.32%-95.04%-236.48%-1254.49%-10211.13%-1273.31%-165.76%
Effective Tax Rate
-12.48%-2.11%129.31%4.30%9.16%1.47%N/AN/A6.73%
Return on Assets
-314.69%-45.50%0.15%-13.44%-8.09%-34.65%-31.50%-35.17%-10.77%
Return On Equity
-616.50%3432.65%-42.52%-14.04%-8.99%-38.77%-34.06%-50.75%-11.51%
Return on Capital Employed
-545.28%-50.31%-1.11%-14.66%-9.77%-38.93%-38.07%-38.93%-12.22%
Liquidity Ratios
Current Ratio
N/AN/AN/A25.06N/AN/AN/A14.2312.53
Quick Ratio
1.4712.1413.6925.0612.4414.2317.7213.9318.75
Cash ratio
1.3311.9810.504.383.061.402.211.403.72
Days of Sales Outstanding
N/AN/A47.2481.7196.3174.73692.3474.7389.01
Days of Inventory outstanding
N/AN/AN/AN/A0.000.00N/AN/A0.00
Operating Cycle
N/AN/AN/AN/A96.3174.73N/AN/A48.15
Days of Payables Outstanding
N/A1.41KN/AN/A338.45156.66N/AN/A169.22
Cash Conversion Cycle
N/AN/AN/AN/A-242.14-81.93N/AN/AN/A
Debt Ratios
Debt Ratio
N/A0.000.00N/A0.000.030.020.100.05
Debt Equity Ratio
N/A-0.59-1.02N/A0.000.030.020.110.05
Long-term Debt to Capitalization
N/A-1.4749.33N/AN/A0.030.020.04N/A
Total Debt to Capitalization
N/A-1.4749.33N/A0.000.030.020.040.02
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-27.23N/A
Cash Flow to Debt Ratio
N/A-53.95-6.19N/A-40.36-7.64-10.23-5.98-2.99
Company Equity Multiplier
1.95-75.42-273.711.041.111.111.081.11-136.33
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-0.04-0.89-9.96-9.77-73.64-9.77-5.42
Free Cash Flow / Operating Cash Flow Ratio
1.081.081.351.041.021.011.001.011.03
Cash Flow Coverage Ratio
N/A-53.95-6.19N/A-40.36-7.64-10.23-5.98-2.99
Short Term Coverage Ratio
N/AN/AN/AN/A-40.36-38.51-88.28-38.51-20.18
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A